RAPID: Collection and Archiving of Vital Data on COVID-19 Vaccine Distribution

  • Funded by National Science Foundation (NSF)
  • Total publications:0 publications

Grant number: 2124825

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $100,000
  • Funder

    National Science Foundation (NSF)
  • Principal Investigator

    Unspecified Ali Hajbabaie
  • Research Location

    United States of America
  • Lead Research Institution

    North Carolina State University
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine logistics and supply chains and distribution strategies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Vaccines that are effective at protecting against COVID-19 were first approved for emergency use in the United States in December, 2020. Since that time, as vaccine supply has steadily increased, vaccines have been distributed to states in phases through a variety of channels, including hospitals, pharmacies, nursing homes, public health departments, and mass vaccination sites in an effort to vaccinate as many citizens as possible to reduce morbidity and mortality. Distributing and administering a vaccine on a large scale over a short time period, particularly under extraordinary cold storage requirements, is a challenging and complex logistical problem. This Rapid Response Research (RAPID) grant supports the collection of time-sensitive data on COVID-19 vaccine distribution and administration from the Centers for Disease Control and Prevention (CDC) and a select number of state public health departments. The collection and archiving of time-sensitive data on the vaccination effort in the US will assist researchers in studying the distribution and enable a more efficient response to future pandemics or natural or man-made disasters. This project will collect data on COVID-19 vaccine allocation, distribution and shipment, administration, and inventory to quantify vaccination performance measures such as lead-times, equity with respect to gender or race/ethnicity, and vaccine spoilage. In addition, the project will collect data on policies and decisions made by states that relate to vaccine distribution/administration including the date and type of eligibility expansion, distribution network, the information system used for managing vaccine distribution, number of provider sites in use at select points in time, existence of race/ethnicity elements in the data tracking, and use of state-wide call center or waiting list. All collected data will be de-identified, stored, and managed in a centralized system eventually to make available (as allowable per privacy rules) to researchers. The project will develop an online vaccination portal, whose main goal is to provide a high-level analysis of the collected data, graphics, and data downloading capabilities.